PAI Partners Acquires 67% Stake in VAMED's European Rehabilitation Business from Fresenius

May 2, 2024

PAI Partners will acquire a 67% stake in VAMED's pan‑European rehabilitation business from Fresenius, with Fresenius retaining a 33% stake. The carved‑out business operates 67 clinics across multiple European countries, employs around 10,000 staff and will operate as a standalone rehabilitation platform focused on operational excellence and further investment.

Buyers
PAI Partners, Fresenius SE & Co. KGaA
Targets
VAMED's European rehabilitation business
Sellers
Fresenius SE & Co. KGaA
Location
Vienna, Austria
Transaction Type
Divestiture

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.